Business
InteguSeal reduces SSIs
InteguSeal reduces SSIs.
About this update from Advanced Medical Solutions Group Plc
[{"type":"text","content":"\n RNS Number : 8461S Advanced Medical Solutions Grp PLC 27 May 2009 \n \n\n\n\n\nFor Immediate Release \n\n\n27 May 2009\n\n\n\n\n\n\nRNS REACH\n\nAdvanced Medical Solutions Group PLC \n('AMS' or the 'Company')\n\nInteguSeal* significantly reduces surgical site infection\nin high risk cardiac surgery patients\n\nWinsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, today announces that in two clinical papers presented at a meeting earlier this month of the European Society of Cardiovascular Surgery (ESCVS) in Warsaw, Poland, InteguSeal* microbial sealant was shown to significantly reduce surgical site infection (SSI) after cardiac surgery.\n\nPost-operative infection of the wound site is an important cause of morbidity and mortality in patients undergoing cardiac surgery. The use of InteguSeal* microbial sealant, a product developed by AMS, and marketed worldwide by Kimberly-Clark, was evaluated as a means of reducing SSIs in two studies reported at the recent meeting.\n\nIn a study by Dohmen et al from the Department of Cardiovascular Surgery, Charite Hospital, Berlin, Germany, 291 consecutive patients were studied between January 2006 and July 2008. They were divided into two groups comprising a control group of 132 patients receiving standard institutional pre-operative preparation and a group of 159 patients who received InteguSeal* in addition. The clinical end point showed a statistically significant decrease of SSIs in the InteguSeal* group to 2.5% compared with the control group of 7.6%.\n\nThe authors concluded that the use of InteguSeal*, in addition to standard pre-operative preparation, provides a statistically significant reduction in the risk of SSIs in high risk patients undergoing cardiac surgery.\n\nIn another study reported at the meeting, F. Pekar from the Cardiovascular Institute SUSCCH in Banska Bystrica, Slovakia, observed 684 consecutive cardiac patients operated on between February 2007 and October 2008 with the use of InteguSeal* microbial sealant, and compared this population with 407 patients operated on between January 2006 and January 2007 without InteguSeal*. \n\nThe prevalence of SSI in the control group was 4.18%...